China NMPA Product Recall - Soft (hydrophilic) contact lens

On November 14, 2022, the National Medical Products Administration (NMPA) issued an announcement regarding a voluntary Class III recall by CooperVision Inc., as reported by its subsidiary, CooperVision Products Trading (Shanghai) Co., Ltd. The recall, referenced under NMPA Index No. JGXX-2022-10285, targets specific models and batches of Soft (hydrophilic) Contact Lenses (Registration Certificate No.: 20213160048). The core issue identified was the presence of incorrect labeling on the bubble cups of the affected products. This proactive measure, initiated by CooperVision Inc., demonstrates the company's commitment to upholding product quality and regulatory compliance within the medical device sector. While the document does not specify inspection dates, the recall's publication date serves as the primary timestamp for this regulatory action. The required action involves the voluntary removal of these mislabeled contact lenses from the market, with detailed information on the impacted models and specifications provided in an accompanying Medical Device Recall Table. This ensures that only accurately labeled and compliant products are available to consumers, safeguarding public health.